Journal History

2003 Marine Drugs was founded at the Ocean University of China.
The inaugural issue was released. Marine Drugs was published as a quarterly journal.
2005 Marine Drugs was indexed in Science Citation Index Expanded (SCIE)—Web of Science (Clarivate Analytics), starting with Volume 3 (Issue 1).
2007 Marine Drugs was indexed in PubMed.
2010 Marine Drugs adopted a monthly publication schedule. 
Marine Drugs was indexed in Scopus (Elsevier), starting with Volume 5 (Issue 1).
The Impact Factor increased to 3.471.
2012 The Impact Factor increased to 3.854.
2013 Marine Drugs received its 2012 Impact Factor (3.978), ranked 6/59 in “Medicinal Chemistry”.
Marine Drugs launched its Best Paper Award.
2014 Marine Drugs received its 2013 Impact Factor (3.512), ranked 10/58 in “Medicinal Chemistry”.
2015 Marine Drugs received its 2014 Impact Factor (2.853), ranked 22/59 in “Medicinal Chemistry”.
Marine Drugs created its Twitter account.
2016 Marine Drugs received its 2015 Impact Factor (3.345), ranked 13/59 in “Medicinal Chemistry”.
Marine Drugs announced the first edition of the Young Investigator Award.
2017 Marine Drugs received its 2016 Impact Factor (3.503), ranked 13/60 in “Medicinal Chemistry”.
2018 Marine Drugs received its 2017 Impact Factor (4.379), ranked 5/59 in “Medicinal Chemistry”.
2019 Marine Drugs received its 2018 Impact Factor (3.772), ranked 15/61 (Q1) in “Medicinal Chemistry”.
2020 The Impact Factor increased to 4.073.
Marine Drugs received its CiteScore (2019) of 5.1.
The Australia New Zealand Marine Biotechnology Society (ANZMBS) became affiliated to Marine Drugs.
2021 Marine Drugs received its 2020 Impact Factor (5.118), ranked 12/62 (Q1) in “Medicinal Chemistry”, and ranked 60/276 (Q1) in "Pharmacology & Pharmacy".
Marine Drugs received its CiteScore (2020) of 6.4, ranked 86% in “Pharmacology, Toxicology and Pharmaceutics (miscellaneous)”, ranked 83% in “Pharmaceutical Science”, ranked 78% in “Drug Discovery”.
2022 Marine Drugs received its 2021 Impact Factor (6.085), ranked 10/63 (Q1) in “Chemistry, Medicinal”, ranked 48/279 (Q1) in “Pharmacology & Pharmacy”.
Marine Drugs received its CiteScore (2021) of 8.1, ranked 88% in Category “Pharmacology, Toxicology and Pharmaceutics (miscellaneous)”, ranked 86% in “Pharmaceutical Science”, ranked 82% in “Drug Discovery”.
Marine Drugs established the following sections:
  • Structural Studies on Marine Natural Products;
  • Marine Pharmacology;
  • Marine Toxins;
  • Biomaterials of Marine Origin;
  • Marine Biotechnology Related to Drug Discovery or Production;
  • Synthesis and Medicinal Chemistry of Marine Natural Products;
  • Marine-Derived Ingredients for Drugs, Cosmeceuticals and Nutraceuticals;
  • Marine Chemoecology for Drug Discovery.
2023 The year 2023 marks the 20th Anniversary of Marine Drugs.
Marine Drugs received its 2022 Impact Factor (5.4), ranked 13/60 (Q1) in JCR Category “Chemistry, Medicinal” and 51/277 (Q1) in JCR Category “Pharmacology, Pharmacy”.
Marine Drugs received its CiteScore (2022) of 9.6, ranked 92% in Category “Pharmacology, Toxicology and Pharmaceutics (miscellaneous)”, ranked 86% in “Pharmaceutical Science”, ranked 84% in “Drug Discovery”.
2024

Marine Drugs received its 2023 Impact Factor (4.9), ranked 13/72 (Q1) in JCR Category “Chemistry, Medicinal” and 45/354 (Q1) in JCR Category “Pharmacology, Pharmacy”.
Marine Drugs received its CiteScore (2023) of 9.6, ranked 91% in Category “Pharmacology, Toxicology and Pharmaceutics (miscellaneous)”, ranked 89% in “Pharmaceutical Science”, ranked 86% in “Drug Discovery”.

Editor-in-Chief

2003–2005 Editor-in-Chief: Prof. Dr. Hua-Shi Guan
2005–2009 Editor-in-Chief: Prof. Dr. Peter Proksch
2009–2013 Editor-in-Chief: Prof. Dr. Hartmut Laatsch
2014–2018 Editor-in-Chief: Prof. Dr. Alejandro M. Mayer
2018–2022 Editor-in-Chief: Prof. Dr. Orazio Taglialatela-Scafati
2022–present Editor-in-Chief: Prof. Dr. Bill J. Baker

Section Editor-in-Chief

2022 Section Editor-in-Cheif: Prof. Dr. Bill J. Baker for the Section on Marine Toxins
2022–present Section Editor-in-Cheif: Prof. Dr. Anake Kijjoa for the Section on Structural Studies on Marine Natural Products
Section Editor-in-Cheif:
Prof. Dr. Vassilios Roussis for the Section on Marine Chemoecology for Drug Discovery
Section Editor-in-Cheif:
Prof. Dr. Marialuisa Menna for the Section on Synthesis and Medicinal Chemistry of Marine Natural Products
Section Editor-in-Cheif:
Prof. Dr. Marc Diederich for the Section on Marine Pharmacology
Section Editor-in-Cheif:
Prof. Dr. Hermann Ehrlich for the Section on Biomaterials of Marine Origin
Section Editor-in-Cheif: 
Prof. Dr. Yue-Wei Guo for the Section on Marine-Derived Ingredients for Drugs, Cosmeceuticals and Nutraceuticals
Section Editor-in-Cheif:
Dr. Ipek Kurtboke for the Section on Marine Biotechnology Related to Drug Discovery or Production
Section Editor-in-Cheif:
Dr. Andrew Turner for the Section on Marine Toxins
 
 
Back to TopTop